New prostate cancer treatment praised by first recipient at RUH
The Royal United Hospital in Bath has introduced a new high-precision radiotherapy treatment for prostate cancer that reduces the required sessions from 20 to five. The first patient, Derek Chase, praised the efficiency and convenience of the new protocol.
Why it matters
This medical advancement significantly improves patient quality of life and increases the capacity of the NHS to treat prostate cancer.
Share Save Add as preferred on Google Royal United Hospitals Bath NHS Foundation Trust. Derek Chase had just five doses of radiotherapy over two weeks, instead of the usual 20 doses The first person to be given new high-precision radiography treatment for prostate cancer at the Royal United Hospital (RUH) has said it was "the NHS at its best".
Derek Chase, 73, a retired GP from Calne, Wiltshire, is the first patient to receive Stereotactic ablative radiotherapy (SABR) at the Bath hospital - a treatment that cuts the number of sessions from 20 to five.
The treatment, which is already offered to some lung and brain cancer patients, will now be available to thousands of men across the country with low and intermediate-risk prostate cancer.
Chase said the five doses over two weeks were "so much more convenient, not just for patients but their loved ones too".
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in